Table1. IAPP immunostaining for pancreatic islets.
| |
Large Islets |
Medium Islets |
||||||||||
|
Total Islet |
% Ins |
% Glu |
% SRIF |
% IAPP |
% IAPP/Ins |
Total Islet |
% Ins |
% Glu |
% SRIF |
% IAPP |
% IAPP/Ins |
|
| |
Insulinomas (n = 3) |
|||||||||||
|
Csse 1. 17/F |
65.2 |
64.8 |
21.8 |
12 |
42.6 |
40 |
24.2 |
66.2 |
22.4 |
11.3 |
36.5 |
55.1 |
|
Case 2. 52/M |
53.6 |
61 |
29.7 |
8.7 |
39 |
72.7 |
22 |
53.2 |
33.2 |
10.5 |
43 |
80.8 |
|
Case 3. 66/F |
65.8 |
55.5 |
32.8 |
11.8 |
42.5 |
76.7 |
25.9 |
66.7 |
21.1 |
12.5 |
41.6 |
62.4 |
| |
Somatostatinoma (n = 1) |
|||||||||||
|
Case 1. 42/F |
58.7 |
75 |
16.3 |
7.3 |
24 |
40.9 |
19 |
71.6 |
15.1 |
14 |
40.4 |
56.4 |
| |
PPoma (n = 1) |
|||||||||||
|
Case 1. 33/M |
64 |
58.2 |
27.8 |
14 |
27 |
42.2 |
19.5 |
59.4 |
23.2 |
17.7 |
41.3 |
69.5 |
| |
Non-functioning tumor (n = 1) |
|||||||||||
|
Case 1. 66/M |
94.5 |
58.2 |
29.5 |
9.7 |
36.7 |
38.8 |
26.9 |
58.4 |
37.4 |
13.8 |
37 |
63.3 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Mean (n = 6) |
67 |
62.1 |
26.3 |
10.6 |
35.3 |
51.9 |
22.9 |
62.6 |
23.7 |
13.3 |
40 |
64.6 |
|
SE |
5.8 |
2.9 |
2.5 |
1 |
3.3 |
7.2 |
1.3 |
2.8 |
2.5 |
1 |
1.1 |
3.9 |
Ins, insulin; Glu, glucagon; SRIF, somatostatin; IAPP, islet amyloid polypeptide.